Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Posch

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Intensive Care Medicine|May 19, 2021
Evaluation and calibration of SAPS 3 in patients with COVID-19 admitted to intensive care unitsPhilipp G H Metnitz, Rui P Moreno, Tobias Fellinger, et al.
Statistical Methods in Medical Research|September 21, 2020
Efficient two-stage sequential arrays of proof of concept studies for pharmaceutical portfoliosLinchen He, Linqiu Du, Zoran Antonijevic, et al.
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
Psychiatric Services (Washington, D.C.)|December 3, 2010
Availability of mental health service providers and suicide rates in Austria: a nationwide studyNestor D Kapusta, Martin Posch, Thomas Niederkrotenthaler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2008
Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind studyGottfried Kranz, Dietrich Haubenberger, Bernhard Voller, et al.
Orphanet Journal of Rare Diseases|February 22, 2016
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditionsSteffen Unkel, Christian Röver, Nigel Stallard, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Determination of the optimal sample size for a clinical trial accounting for the population sizeNigel Stallard, Frank Miller, Simon Day, et al.
Statistics in Medicine|March 7, 2009
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncologyWerner Brannath, Emmanuel Zuber, Michael Branson, et al.
Pharmaceutical Statistics|April 28, 2021
The use of external controls: To what extent can it currently be recommended?Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, et al.
Trials|June 15, 2023
On the use of non-concurrent controls in platform trials: a scoping reviewMarta Bofill Roig, Cora Burgwinkel, Ursula Garczarek, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Intensive Care Medicine|May 19, 2021
Evaluation and calibration of SAPS 3 in patients with COVID-19 admitted to intensive care unitsPhilipp G H Metnitz, Rui P Moreno, Tobias Fellinger, et al.
Statistical Methods in Medical Research|September 21, 2020
Efficient two-stage sequential arrays of proof of concept studies for pharmaceutical portfoliosLinchen He, Linqiu Du, Zoran Antonijevic, et al.
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
Psychiatric Services (Washington, D.C.)|December 3, 2010
Availability of mental health service providers and suicide rates in Austria: a nationwide studyNestor D Kapusta, Martin Posch, Thomas Niederkrotenthaler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2008
Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind studyGottfried Kranz, Dietrich Haubenberger, Bernhard Voller, et al.
Orphanet Journal of Rare Diseases|February 22, 2016
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditionsSteffen Unkel, Christian Röver, Nigel Stallard, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Determination of the optimal sample size for a clinical trial accounting for the population sizeNigel Stallard, Frank Miller, Simon Day, et al.
Statistics in Medicine|March 7, 2009
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncologyWerner Brannath, Emmanuel Zuber, Michael Branson, et al.
Pharmaceutical Statistics|April 28, 2021
The use of external controls: To what extent can it currently be recommended?Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, et al.
Trials|June 15, 2023
On the use of non-concurrent controls in platform trials: a scoping reviewMarta Bofill Roig, Cora Burgwinkel, Ursula Garczarek, et al.
Pageof 17